Primary information |
---|
PRRID | PRRID_1012 |
Ligand Name | Resquimod |
Source | 3M Pharma (others) |
Sequence of ligand | CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N |
Length | NA |
Type | imidazoquinolines |
Occurence | Synthetic |
Role of Ligand | Immunostimulant |
Name of receptor | Toll-like receptor 7/8 (TLR7/8) |
Type of receptor | Toll-like receptor (TLR) |
Source | Human |
Localization | NA |
Domain | NA |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | Recognition of extracellular PAMPs
Activation leads to pro-inflammatory cytokines and type I IFNs production
Set the pace for an adaptive immune response via T and B cells. |
Assay used | NA |
PMID | 23017246 |
Year of Publication | 2012 |
Pubchem assay | NA |
Primary information |
---|
PRRID | PRRID_1012 |
Ligand Name | Resquimod |
Source | 3M Pharma (others) |
Sequence of ligand | CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N |
Length | NA |
Type | imidazoquinolines |
Occurence | Synthetic |
Role of Ligand | Immunostimulant |
Name of receptor | Toll-like receptor 7/8 (TLR7/8) |
Type of receptor | Toll-like receptor (TLR) |
Source | Human |
Localization | NA |
Domain | NA |
Sequence of Receptor | NA |
Swiss prot ID | NA |
Length Of Receptor | NA |
Function | Recognition of extracellular PAMPs
Activation leads to pro-inflammatory cytokines and type I IFNs production
Set the pace for an adaptive immune response via T and B cells. |
Assay used | NA |
PMID | 23017246 |
Year of Publication | 2012 |
Pubchem assay | NA |